Aquila Life Sciences Private Limited
About Aquila Life Sciences Private Limited
Data last updated:
Aquila Life Sciences Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2016PTC076859. Its GSTIN is 09AAOCA6148G1ZD (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Himanshu Mani Tripathi and Sushil Kumar Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Arun Tripathi 17/191B Rasulpur Indra Nagar, Gorakhpur, Uttar Pradesh, India – 273009.
As per the financials filed for FY 2025, the company reported a revenue of ₹93.1 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹28,205 (net margin 0.3%) and EBITDA of ₹38,115 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 36% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aquila Life Sciences Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Arun Tripathi 17/191B Rasulpur Indra Nagar, Gorakhpur, Uttar Pradesh, India – 273009
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aquila Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aquila Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aquila Life Sciences Private Limited, buy the company report.
Financials of Aquila Life Sciences Private Limited
FY 2024 filings availableAquila Life Sciences Private Limited reported revenue of ₹93.1 Lakh (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 22% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 36%. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38,115 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28,205 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aquila Life Sciences Private Limited, buy the company report.
Board of directors of Aquila Life Sciences Private Limited
Aquila Life Sciences has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Himanshu Mani Tripathi | Director | 25 Feb 2016 | 10 Years 7 Months | Current |
| Sushil Kumar Tripathi | Director | 25 Feb 2016 | 10 Years 7 Months | Current |
| Arun Kumar Tripathi | Director | 10 Jul 2017 | 9 Years 3 Months | Current |
Auditor
Aquila Life Sciences Private Limited is audited by Vikram Choudhary & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vikram Choudhary & CO. | FY 2023 | 030965C |
Shareholding
The shareholding of Aquila Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aquila Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aquila Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aquila Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aquila Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAOCA6148G1ZD | Uttar Pradesh | Active | 02 Apr 2019 |
To see the full GST registrations and return filing status of Aquila Life Sciences Private Limited, buy the company report.
Recent activity
Aquila Life Sciences Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Arun Kumar Tripathi was appointed as Director on 10 Jul 2017.
Frequently asked questions
Aquila Life Sciences is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 February 2016 (10+ years old) and is registered under CIN U24233UP2016PTC076859.
Aquila Life Sciences has 3 current directors:
- Himanshu Mani Tripathi - Director
- Sushil Kumar Tripathi - Director
- Arun Kumar Tripathi - Director
The latest financial statements of Aquila Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Aquila Life Sciences is 09AAOCA6148G1ZD, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Aquila Life Sciences is U24233UP2016PTC076859. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aquila Life Sciences was incorporated on 25 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
Arun Kumar Tripathi was appointed as Director on 10 Jul 2017. Himanshu Mani Tripathi was appointed as Director on 25 Feb 2016. Sushil Kumar Tripathi was appointed as Director on 25 Feb 2016.
The registered office of Aquila Life Sciences is at CO Arun Tripathi 17191B Rasulpur Indra Nagar, Gorakhpur, Uttar Pradesh, India – 273009.
Aquila Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Aquila Life Sciences is compliant as of 23 July 2026. The company is actively filing with the Registrar of Companies.